Being Bridgette
Humanizing science
Report from the community HIV cure research workshop
HIV cure research highlights
HIV and aging at CROI
‘There are many added layers and dimensions to consider’
The NADIA study
Second-line treatment recommendations
Virtual CROI 2022: Testing and treating
Highlights from Virtual CROI 2022
When HIV therapy fails: Terms of ART
A treatment glossary
When HIV therapy fails: That’s not all, folks
An explanation of some of the technical language in the DHHS’ HIV treatment guidelines
When HIV therapy fails: For treatment-experienced individuals who are experiencing virologic failure
Key considerations and recommendations from the HIV treatment guidelines of the U.S. Department of Health and Human Services (DHHS)
When HIV therapy fails
Some basic information from U.S. treatment guidelines
Briefly May+Jun 2022
Cabenuva long-acting injectable no longer requires a month of oral lead-in medication
Drug Class List
An A-to-Z listing of the medications in the drug guide.
Looking ahead
What’s on the horizon—new drugs in development
DHHS Recommendations
Guidelines for people starting HIV therapy for the first time
Contributors
The people behind the 2022 HIV Drug Guide
FDA approves two-month shot of Cabenuva for HIV
FDA has approved Cabenuva, the long-acting injectable regimen, as a shot that can be taken every two months instead of monthly for HIV treatment
25 years of HAART
The long journey continues
Briefly Jan+Feb 2022
New injectable PrEP given every two months: Apretude
The Category Is: Virtual realness
Readers respond to questions about telehealth services
Being Bridgette
As a woman
The Category Is Sep+Oct 2021
Basic Realness
Roadside assistance
HIV treatment can be costly, but there's help
HIV life cycle
Different drug classes interrupt the virus from replicating at various stages
12 things to know about HIV treatment
It is recommended that everyone living with HIV be on HIV treatment, and as soon as possible after diagnosis.
Getting around
In this guide, HIV drugs are grouped into eight categories —plus, additional categories for select non-HIV drugs and PrEP
DHHS Recommendations
DHHS Guidelines for people starting HIV therapy for the first time
Editor’s note Mar+Apr 2021
This issue of Positively Aware magazine is our 25th Annual HIV Drug Guide, and it’s been quite a ride.
A great love endures
Remembering the humility and joy of Timothy Ray Brown
Mind, body, and medicine
Taking care of your mental health while living with HIV
Stories of women remaking a life
Overcoming trauma and stigma to live free
Top news from AIDS2020: Virtual
Highlights from the AIDS2020: Virtual conference
Fatty (t)issues
Weight gain and HIV medications
New long-acting drugs in development
Trend towards long-acting HIV medications continues
Taking meds monthly—or possibly once a year
A look at drugs in development for HIV treatment and prevention
What's Cooking?
A sneak peak at some of the new drugs coming soon
2020 HIV Drug Chart
A quick guide to the most commonly used HIV medications
HIV Life Cycle
Different drug classes interrupt the virus from replicating at various stages
Choice Options
DHHS Guidelines for people starting HIV therapy for the first time
The Waxing and Waning of HIV Drugs
Medications come and go, but the goal is still the same
Weighty Concerns
What we know for now about weight gain with HIV medications
Contributors
Our 2020 HIV Drug Guide Contributors
Briefly
Pregnancy and dolutegravir; AIDS Quilt finds a new home; survey on women living with HIV; and more
The future is already here
Technological advances in HIV treatment and prevention
Briefly
FDA approves Descovy for PrEP; Delstrigo and Pifeltro approved for switch treatment; Bictegravir, dolutegravir and Tybost for children; and more.
Exciting news from Mexico City
Fostemsavir; long-acting injectable; vaginal ring
Dolutegravir during pregnancy
Based on new data, the World Health Organization (WHO) recommended dolutegravir as a preferred HIV drug for all populations living with HIV, including pregnant women and those wanting to conceive.
HIV meds just four days a week?
And other conference highlights including new long-acting drug GS-6207; PrEP on demand; HIV treatment = prevention.
Building blocks for a healthy life
Building blocks for a healthy life, with insights from a nurse educator
Briefly
Biktarvy and antacids. Descovy FDA hearing. Updated guidelines for transgender individuals. Biktarvy and kids. PrEP4Love. Michael Johnson freed.
Editor's Note
Note to my younger self.
Truvada Safety
Talking about PrEP and HIV treatment in a time of class action lawsuits
Briefly
Monthly injectable HIV med on the way; HIV pharma sued over pricing practices; Australian PrEP advocate talks about his new HIV status; tenofovir class action lawsuits
Healthiness in HIV
A look in the poster hall
Drugs in development
Monthly injections plus inhibitors of viral capsid and maturation
Briefly: May+June 2019
New two-drug regimen gets FDA approval. Transgender filmmaker debuts new documentary. Project Inform closes. First kidney transplant from donor living with HIV.
Find Your 2020 HIV Drug Here
An A to Z listing of the drugs in the 2020 HIV Drug Guide
Coming Attractions
A sneak peak at some of the new drugs coming soon
An Ensemble Cast
How different drug classes play their part in the HIV lifecycle
Your Map to the Stars
Getting the most out of your drug guide
On With the Show!
Moving beyond your diagnosis—finding a provider, knowing your rights, and more
Supporting Role
HIV treatment can be costly, but there’s help
When Drugs Collide!
Understanding drug interactions
Rising to the Occasion
DHHS guideline recommendations for first-time therapy in HIV
And the Nominees Are…
A quick look at the recommendations for first-time therapy
The Conversation: March & April 2019
Mixed emotions for a long-term survivor. Peer education in prison. Loving the HIV drug guides and charts.
Opening Credits
Contributors to the 2019 HIV Drug Guide
Front Cover Backstory: March & April 2019
The experience is your own, but you’re not alone in the room
The road ahead
New drugs, new options on the horizon
Pennies from above
HIV treatment can be costly, but there’s help
Standard practice
DHHS treatment guidelines for first-time HIV therapy
The future of HIV therapy
New strategies are here—and more are on the way, says W. David Hardy, MD